Table 2.
Changes (mean ± SD) in resting glucose (GLU) and insulin (INS) concentrations, the homeostasis model assessment (HOMA) index, whole blood glycosylated hemoglobin (HbA1c) concentration, oral glucose tolerance test (OGTT) results, total cholesterol (TC), triacylglycerol (TG), low- (LDLC) and high-density lipoprotein cholesterols (HDLC) concentrations before (pre) and after (post) ascending (ASW; n = 15) and descending stair walking (DSW; n = 15).
| Group | pre | post | Group | pre | post | Group | pre | post | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLU (mg/dL) | ASW | 111.5 ± 6.9 | 106.4 ± 6.6# | INS (pmol/L) | ASW | 83.3 ± 6.9 | 79.1 ± 5.6# | HOMA (A.U.) | ASW | 2.64 ± 0.32 | 2.39 ± 0.24# |
| DSW | 113.9 ± 15.5 | 104.2 ± 18.4#,* | DSW | 85.4 ± 7.1 | 69.2 ± 5.3#,* | DSW | 2.74 ± 0.32 | 2.02 ± 0.28#,* | |||
| HbA1c (%) | ASW | 5.86 ± 0.35 | 5.88 ± 0.65 | OGTT (mg/dL/2 h) | ASW | 816.4 ± 69.6 | 798.6 ± 86.1# | TG (md/dL) | ASW | 105.9 ± 8.6 | 97.9 ± 11.3# |
| DSW | 5.87 ± 0.27 | 5.58 ± 0.38#,* | DSW | 833.7 ± 61.8 | 733.6 ± 80.5#,* | DSW | 109.3 ± 8.4 | 88.1 ± 19.6#,* | |||
| TC (md/dL) | ASW | 208.5 ± 18.5 | 201.1 ± 14.8# | LDLC (md/dL) | ASW | 125.9 ± 12.5 | 116.0 ± 7.9# | HDLC (md/dL) | ASW | 64.4 ± 6.1 | 64.2 ± 5.9 |
| DSW | 215.2 ± 20.3 | 194.5 ± 24.9# | DSW | 127.5 ± 11.9 | 110.5 ± 13.3#,* | DSW | 62.1 ± 5.7 | 68.3 ± 7.4#,* |
#: significant (p ≤ 0.05) difference compared with the pre-training level. *: significant (p ≤ 0.05) difference compared with the ASW group.